Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes.

[1]  K. Paigen,et al.  A simple, rapid, and sensitive DNA assay procedure. , 1980, Analytical biochemistry.

[2]  William N. Kelley,et al.  Textbook of rheumatology , 1985 .

[3]  Roland W. Moskowitz,et al.  Osteoarthritis: Diagnosis and Medical/Surgical Management , 1992 .

[4]  C. Rorabeck,et al.  Osteoarthritis in the human knee: a dynamic process of cartilage matrix degradation, synthesis and reorganization. , 1993, Agents and actions. Supplements.

[5]  S. Jimenez,et al.  Formation of nodular structures resembling mature articular cartilage in long-term primary cultures of human fetal epiphyseal chondrocytes on a hydrogel substrate. , 1994, Arthritis and rheumatism.

[6]  J. Cheng,et al.  Structure of the human aggrecan gene: exon-intron organization and association with the protein domains. , 1995, The Biochemical journal.

[7]  D. Eyre,et al.  Collagen structure and cartilage matrix integrity. , 1995, The Journal of rheumatology. Supplement.

[8]  S. Jimenez,et al.  Characterization of human type II procollagen and collagen-specific antibodies and their application to the study of human type II collagen processing and ultrastructure. , 1997, Matrix biology : journal of the International Society for Matrix Biology.

[9]  J. Sandy,et al.  Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine. , 1998, The Biochemical journal.

[10]  P. Franchimont,et al.  Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. , 1998, Osteoarthritis and cartilage.

[11]  J. Sandy,et al.  Chondrocyte-mediated catabolism of aggrecan: evidence for a glycosylphosphatidylinositol-linked protein in the aggrecanase response to interleukin-1 or retinoic acid. , 1999, Archives of biochemistry and biophysics.

[12]  Leslie J. Crofford,et al.  Primer on the Rheumatic Diseases , 1999 .

[13]  G. R. Dodge,et al.  Effects of interleukin-1β and tumor necrosis factor-α on expression of matrix-related genes by cultured equine articular chondrocytes , 2000 .

[14]  P. Patwari,et al.  Mannosamine inhibits aggrecanase-mediated changes in the physical properties and biochemical composition of articular cartilage. , 2000, Archives of biochemistry and biophysics.

[15]  E. Vignon,et al.  Glucosamine sulfate modulates dysregulated activities of human osteoarthritic chondrocytes in vitro. , 2000, Osteoarthritis and cartilage.

[16]  J. Fenton,et al.  Glucosamine HCl reduces equine articular cartilage degradation in explant culture. , 2000, Osteoarthritis and cartilage.

[17]  Joan C. Woodward,et al.  In Vivo Chondroprotection and Metabolic Synergy of Glucosamine and Chondroitin Sulfate , 2000, Clinical orthopaedics and related research.

[18]  D. Felson,et al.  Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. , 2000, JAMA.

[19]  I. G. Fantus,et al.  Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. , 2000, Diabetes.

[20]  L. Singh,et al.  Hexosamine-induced fibronectin protein synthesis in mesangial cells is associated with increases in cAMP responsive element binding (CREB) phosphorylation and nuclear CREB: the involvement of protein kinases A and C. , 2001, Diabetes.

[21]  K. A. Johnson,et al.  Effects of an orally administered mixture of chondroitin sulfate, glucosamine hydrochloride and manganese ascorbate on synovial fluid chondroitin sulfate 3B3 and 7D4 epitope in a canine cruciate ligament transection model of osteoarthritis. , 2001, Osteoarthritis and cartilage.

[22]  R. Reddy,et al.  Preferential incorporation of glucosamine into the galactosamine moieties of chondroitin sulfates in articular cartilage explants. , 2001, Arthritis and rheumatism.

[23]  P. Dieppe,et al.  Glucosamine for osteoarthritis: magic, hype, or confusion? , 2001, BMJ : British Medical Journal.

[24]  Eric Lejeune,et al.  Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial , 2001, The Lancet.

[25]  J. Magdalou,et al.  Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1beta-mediated effects in rat chondrocytes. , 2001, Arthritis and rheumatism.

[26]  R. Hughes,et al.  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee. , 2002, Rheumatology.

[27]  R. Considine,et al.  Hexosamines regulate leptin production in 3T3-L1 adipocytes through transcriptional mechanisms. , 2002, Endocrinology.

[28]  J. Magdalou,et al.  Glucosamine modulates IL‐1‐induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF‐κB pathway , 2002, FEBS Letters.

[29]  K. Thai,et al.  Flux through the hexosamine pathway is a determinant of nuclear factor kappaB- dependent promoter activation. , 2002, Diabetes.

[30]  I. G. Fantus,et al.  The Hexosamine Pathway Regulates the Plasminogen Activator Inhibitor-1 Gene Promoter and Sp1 Transcriptional Activation through Protein Kinase C-βI and -δ* , 2002, The Journal of Biological Chemistry.

[31]  J. Sandy,et al.  Activation of the Proteolytic Activity of ADAMTS4 (Aggrecanase-1) by C-terminal Truncation* , 2002, The Journal of Biological Chemistry.